Global Primary Hyperoxaluria Drug Market Insights and Forecast to 2026

Publisher Name :
Date: 01-Jul-2020
No. of pages: 114
Inquire Before Buying

Primary Hyperoxaluria Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Primary Hyperoxaluria Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Primary Hyperoxaluria Drug market is segmented into

- ALLN-230

- DCR-PHXC

- ALN-GO1

- Others

Segment by Application, the Primary Hyperoxaluria Drug market is segmented into

- Hospital

- Clinic

- Others

Regional and Country-level Analysis

The Primary Hyperoxaluria Drug market is analysed and market size information is provided by regions (countries).

The key regions covered in the Primary Hyperoxaluria Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Primary Hyperoxaluria Drug Market Share Analysis

Primary Hyperoxaluria Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Primary Hyperoxaluria Drug business, the date to enter into the Primary Hyperoxaluria Drug market, Primary Hyperoxaluria Drug product introduction, recent developments, etc.

The major vendors covered:

- Allena Pharmaceuticals Inc

- Alnylam Pharmaceuticals Inc

- Dicerna Pharmaceuticals Inc

- Intellia Therapeutics Inc

- OxThera AB

- ...

Global Primary Hyperoxaluria Drug Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Primary Hyperoxaluria Drug Product Introduction
1.2 Market Segments
1.3 Key Primary Hyperoxaluria Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Primary Hyperoxaluria Drug Market Size Growth Rate by Type
1.4.2 ALLN-230
1.4.3 DCR-PHXC
1.4.4 ALN-GO1
1.4.5 Others
1.5 Market by Application
1.5.1 Global Primary Hyperoxaluria Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Primary Hyperoxaluria Drug Market Size, Estimates and Forecasts
2.1.1 Global Primary Hyperoxaluria Drug Revenue 2015-2026
2.1.2 Global Primary Hyperoxaluria Drug Sales 2015-2026
2.2 Global Primary Hyperoxaluria Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Primary Hyperoxaluria Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Primary Hyperoxaluria Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Primary Hyperoxaluria Drug Competitor Landscape by Players
3.1 Primary Hyperoxaluria Drug Sales by Manufacturers
3.1.1 Primary Hyperoxaluria Drug Sales by Manufacturers (2015-2020)
3.1.2 Primary Hyperoxaluria Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Primary Hyperoxaluria Drug Revenue by Manufacturers
3.2.1 Primary Hyperoxaluria Drug Revenue by Manufacturers (2015-2020)
3.2.2 Primary Hyperoxaluria Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Primary Hyperoxaluria Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Primary Hyperoxaluria Drug Revenue in 2019
3.2.5 Global Primary Hyperoxaluria Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Primary Hyperoxaluria Drug Price by Manufacturers
3.4 Primary Hyperoxaluria Drug Manufacturing Base Distribution, Product Types
3.4.1 Primary Hyperoxaluria Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Primary Hyperoxaluria Drug Product Type
3.4.3 Date of International Manufacturers Enter into Primary Hyperoxaluria Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Primary Hyperoxaluria Drug Market Size by Type (2015-2020)
4.1.1 Global Primary Hyperoxaluria Drug Sales by Type (2015-2020)
4.1.2 Global Primary Hyperoxaluria Drug Revenue by Type (2015-2020)
4.1.3 Primary Hyperoxaluria Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Primary Hyperoxaluria Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Primary Hyperoxaluria Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Primary Hyperoxaluria Drug Revenue Forecast by Type (2021-2026)
4.2.3 Primary Hyperoxaluria Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Primary Hyperoxaluria Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Primary Hyperoxaluria Drug Market Size by Application (2015-2020)
5.1.1 Global Primary Hyperoxaluria Drug Sales by Application (2015-2020)
5.1.2 Global Primary Hyperoxaluria Drug Revenue by Application (2015-2020)
5.1.3 Primary Hyperoxaluria Drug Price by Application (2015-2020)
5.2 Primary Hyperoxaluria Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Primary Hyperoxaluria Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Primary Hyperoxaluria Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Primary Hyperoxaluria Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Primary Hyperoxaluria Drug by Country
6.1.1 North America Primary Hyperoxaluria Drug Sales by Country
6.1.2 North America Primary Hyperoxaluria Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Primary Hyperoxaluria Drug Market Facts & Figures by Type
6.3 North America Primary Hyperoxaluria Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Primary Hyperoxaluria Drug by Country
7.1.1 Europe Primary Hyperoxaluria Drug Sales by Country
7.1.2 Europe Primary Hyperoxaluria Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Primary Hyperoxaluria Drug Market Facts & Figures by Type
7.3 Europe Primary Hyperoxaluria Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Primary Hyperoxaluria Drug by Region
8.1.1 Asia Pacific Primary Hyperoxaluria Drug Sales by Region
8.1.2 Asia Pacific Primary Hyperoxaluria Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Primary Hyperoxaluria Drug Market Facts & Figures by Type
8.3 Asia Pacific Primary Hyperoxaluria Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Primary Hyperoxaluria Drug by Country
9.1.1 Latin America Primary Hyperoxaluria Drug Sales by Country
9.1.2 Latin America Primary Hyperoxaluria Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Primary Hyperoxaluria Drug Market Facts & Figures by Type
9.3 Central & South America Primary Hyperoxaluria Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Primary Hyperoxaluria Drug by Country
10.1.1 Middle East and Africa Primary Hyperoxaluria Drug Sales by Country
10.1.2 Middle East and Africa Primary Hyperoxaluria Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Primary Hyperoxaluria Drug Market Facts & Figures by Type
10.3 Middle East and Africa Primary Hyperoxaluria Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Allena Pharmaceuticals Inc
11.1.1 Allena Pharmaceuticals Inc Corporation Information
11.1.2 Allena Pharmaceuticals Inc Description and Business Overview
11.1.3 Allena Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Products Offered
11.1.5 Allena Pharmaceuticals Inc Related Developments
11.2 Alnylam Pharmaceuticals Inc
11.2.1 Alnylam Pharmaceuticals Inc Corporation Information
11.2.2 Alnylam Pharmaceuticals Inc Description and Business Overview
11.2.3 Alnylam Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Products Offered
11.2.5 Alnylam Pharmaceuticals Inc Related Developments
11.3 Dicerna Pharmaceuticals Inc
11.3.1 Dicerna Pharmaceuticals Inc Corporation Information
11.3.2 Dicerna Pharmaceuticals Inc Description and Business Overview
11.3.3 Dicerna Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Products Offered
11.3.5 Dicerna Pharmaceuticals Inc Related Developments
11.4 Intellia Therapeutics Inc
11.4.1 Intellia Therapeutics Inc Corporation Information
11.4.2 Intellia Therapeutics Inc Description and Business Overview
11.4.3 Intellia Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Intellia Therapeutics Inc Primary Hyperoxaluria Drug Products Offered
11.4.5 Intellia Therapeutics Inc Related Developments
11.5 OxThera AB
11.5.1 OxThera AB Corporation Information
11.5.2 OxThera AB Description and Business Overview
11.5.3 OxThera AB Sales, Revenue and Gross Margin (2015-2020)
11.5.4 OxThera AB Primary Hyperoxaluria Drug Products Offered
11.5.5 OxThera AB Related Developments
11.1 Allena Pharmaceuticals Inc
11.1.1 Allena Pharmaceuticals Inc Corporation Information
11.1.2 Allena Pharmaceuticals Inc Description and Business Overview
11.1.3 Allena Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Products Offered
11.1.5 Allena Pharmaceuticals Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Primary Hyperoxaluria Drug Market Estimates and Projections by Region
12.1.1 Global Primary Hyperoxaluria Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Primary Hyperoxaluria Drug Revenue Forecast by Regions 2021-2026
12.2 North America Primary Hyperoxaluria Drug Market Size Forecast (2021-2026)
12.2.1 North America: Primary Hyperoxaluria Drug Sales Forecast (2021-2026)
12.2.2 North America: Primary Hyperoxaluria Drug Revenue Forecast (2021-2026)
12.2.3 North America: Primary Hyperoxaluria Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Primary Hyperoxaluria Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Primary Hyperoxaluria Drug Sales Forecast (2021-2026)
12.3.2 Europe: Primary Hyperoxaluria Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Primary Hyperoxaluria Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Primary Hyperoxaluria Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Primary Hyperoxaluria Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Primary Hyperoxaluria Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Primary Hyperoxaluria Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Primary Hyperoxaluria Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Primary Hyperoxaluria Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Primary Hyperoxaluria Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Primary Hyperoxaluria Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Primary Hyperoxaluria Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Primary Hyperoxaluria Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Primary Hyperoxaluria Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Primary Hyperoxaluria Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Primary Hyperoxaluria Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Primary Hyperoxaluria Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Primary Hyperoxaluria Drug Market Segments
Table 2. Ranking of Global Top Primary Hyperoxaluria Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Primary Hyperoxaluria Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ALLN-230
Table 5. Major Manufacturers of DCR-PHXC
Table 6. Major Manufacturers of ALN-GO1
Table 7. Major Manufacturers of Others
Table 8. Global Primary Hyperoxaluria Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Primary Hyperoxaluria Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Primary Hyperoxaluria Drug Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Primary Hyperoxaluria Drug Sales Market Share by Regions (2015-2020)
Table 12. Global Primary Hyperoxaluria Drug Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Primary Hyperoxaluria Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Primary Hyperoxaluria Drug Sales Share by Manufacturers (2015-2020)
Table 15. Global Primary Hyperoxaluria Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Primary Hyperoxaluria Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Primary Hyperoxaluria Drug as of 2019)
Table 17. Primary Hyperoxaluria Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Primary Hyperoxaluria Drug Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Primary Hyperoxaluria Drug Price (2015-2020) (USD/Pcs)
Table 20. Primary Hyperoxaluria Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Primary Hyperoxaluria Drug Product Type
Table 22. Date of International Manufacturers Enter into Primary Hyperoxaluria Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Primary Hyperoxaluria Drug Sales by Type (2015-2020) (K Pcs)
Table 25. Global Primary Hyperoxaluria Drug Sales Share by Type (2015-2020)
Table 26. Global Primary Hyperoxaluria Drug Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Primary Hyperoxaluria Drug Revenue Share by Type (2015-2020)
Table 28. Primary Hyperoxaluria Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Primary Hyperoxaluria Drug Sales by Application (2015-2020) (K Pcs)
Table 30. Global Primary Hyperoxaluria Drug Sales Share by Application (2015-2020)
Table 31. North America Primary Hyperoxaluria Drug Sales by Country (2015-2020) (K Pcs)
Table 32. North America Primary Hyperoxaluria Drug Sales Market Share by Country (2015-2020)
Table 33. North America Primary Hyperoxaluria Drug Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Primary Hyperoxaluria Drug Revenue Market Share by Country (2015-2020)
Table 35. North America Primary Hyperoxaluria Drug Sales by Type (2015-2020) (K Pcs)
Table 36. North America Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
Table 37. North America Primary Hyperoxaluria Drug Sales by Application (2015-2020) (K Pcs)
Table 38. North America Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
Table 39. Europe Primary Hyperoxaluria Drug Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Primary Hyperoxaluria Drug Sales Market Share by Country (2015-2020)
Table 41. Europe Primary Hyperoxaluria Drug Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Primary Hyperoxaluria Drug Revenue Market Share by Country (2015-2020)
Table 43. Europe Primary Hyperoxaluria Drug Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
Table 45. Europe Primary Hyperoxaluria Drug Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Primary Hyperoxaluria Drug Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Primary Hyperoxaluria Drug Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Primary Hyperoxaluria Drug Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Primary Hyperoxaluria Drug Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Primary Hyperoxaluria Drug Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Primary Hyperoxaluria Drug Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
Table 55. Latin America Primary Hyperoxaluria Drug Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Primary Hyperoxaluria Drug Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Primary Hyperoxaluria Drug Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Primary Hyperoxaluria Drug Revenue Market Share by Country (2015-2020)
Table 59. Latin America Primary Hyperoxaluria Drug Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
Table 61. Latin America Primary Hyperoxaluria Drug Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Primary Hyperoxaluria Drug Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Primary Hyperoxaluria Drug Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Primary Hyperoxaluria Drug Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Primary Hyperoxaluria Drug Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Primary Hyperoxaluria Drug Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Primary Hyperoxaluria Drug Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
Table 71. Allena Pharmaceuticals Inc Corporation Information
Table 72. Allena Pharmaceuticals Inc Description and Major Businesses
Table 73. Allena Pharmaceuticals Inc Primary Hyperoxaluria Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Allena Pharmaceuticals Inc Product
Table 75. Allena Pharmaceuticals Inc Recent Development
Table 76. Alnylam Pharmaceuticals Inc Corporation Information
Table 77. Alnylam Pharmaceuticals Inc Description and Major Businesses
Table 78. Alnylam Pharmaceuticals Inc Primary Hyperoxaluria Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Alnylam Pharmaceuticals Inc Product
Table 80. Alnylam Pharmaceuticals Inc Recent Development
Table 81. Dicerna Pharmaceuticals Inc Corporation Information
Table 82. Dicerna Pharmaceuticals Inc Description and Major Businesses
Table 83. Dicerna Pharmaceuticals Inc Primary Hyperoxaluria Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Dicerna Pharmaceuticals Inc Product
Table 85. Dicerna Pharmaceuticals Inc Recent Development
Table 86. Intellia Therapeutics Inc Corporation Information
Table 87. Intellia Therapeutics Inc Description and Major Businesses
Table 88. Intellia Therapeutics Inc Primary Hyperoxaluria Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Intellia Therapeutics Inc Product
Table 90. Intellia Therapeutics Inc Recent Development
Table 91. OxThera AB Corporation Information
Table 92. OxThera AB Description and Major Businesses
Table 93. OxThera AB Primary Hyperoxaluria Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. OxThera AB Product
Table 95. OxThera AB Recent Development
Table 96. Global Primary Hyperoxaluria Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 97. Global Primary Hyperoxaluria Drug Sales Market Share Forecast by Regions (2021-2026)
Table 98. Global Primary Hyperoxaluria Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 99. Global Primary Hyperoxaluria Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 100. North America: Primary Hyperoxaluria Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 101. North America: Primary Hyperoxaluria Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 102. Europe: Primary Hyperoxaluria Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. Europe: Primary Hyperoxaluria Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Asia Pacific: Primary Hyperoxaluria Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 105. Asia Pacific: Primary Hyperoxaluria Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 106. Latin America: Primary Hyperoxaluria Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 107. Latin America: Primary Hyperoxaluria Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 108. Middle East and Africa: Primary Hyperoxaluria Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 109. Middle East and Africa: Primary Hyperoxaluria Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 111. Key Challenges
Table 112. Market Risks
Table 113. Main Points Interviewed from Key Primary Hyperoxaluria Drug Players
Table 114. Primary Hyperoxaluria Drug Customers List
Table 115. Primary Hyperoxaluria Drug Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Primary Hyperoxaluria Drug Product Picture
Figure 2. Global Primary Hyperoxaluria Drug Sales Market Share by Type in 2020 & 2026
Figure 3. ALLN-230 Product Picture
Figure 4. DCR-PHXC Product Picture
Figure 5. ALN-GO1 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Primary Hyperoxaluria Drug Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Primary Hyperoxaluria Drug Report Years Considered
Figure 12. Global Primary Hyperoxaluria Drug Market Size 2015-2026 (US$ Million)
Figure 13. Global Primary Hyperoxaluria Drug Sales 2015-2026 (K Pcs)
Figure 14. Global Primary Hyperoxaluria Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Primary Hyperoxaluria Drug Sales Market Share by Region (2015-2020)
Figure 16. Global Primary Hyperoxaluria Drug Sales Market Share by Region in 2019
Figure 17. Global Primary Hyperoxaluria Drug Revenue Market Share by Region (2015-2020)
Figure 18. Global Primary Hyperoxaluria Drug Revenue Market Share by Region in 2019
Figure 19. Global Primary Hyperoxaluria Drug Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Primary Hyperoxaluria Drug Revenue in 2019
Figure 21. Primary Hyperoxaluria Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Primary Hyperoxaluria Drug Sales Market Share by Type (2015-2020)
Figure 23. Global Primary Hyperoxaluria Drug Sales Market Share by Type in 2019
Figure 24. Global Primary Hyperoxaluria Drug Revenue Market Share by Type (2015-2020)
Figure 25. Global Primary Hyperoxaluria Drug Revenue Market Share by Type in 2019
Figure 26. Global Primary Hyperoxaluria Drug Market Share by Price Range (2015-2020)
Figure 27. Global Primary Hyperoxaluria Drug Sales Market Share by Application (2015-2020)
Figure 28. Global Primary Hyperoxaluria Drug Sales Market Share by Application in 2019
Figure 29. Global Primary Hyperoxaluria Drug Revenue Market Share by Application (2015-2020)
Figure 30. Global Primary Hyperoxaluria Drug Revenue Market Share by Application in 2019
Figure 31. North America Primary Hyperoxaluria Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Primary Hyperoxaluria Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Primary Hyperoxaluria Drug Sales Market Share by Country in 2019
Figure 34. North America Primary Hyperoxaluria Drug Revenue Market Share by Country in 2019
Figure 35. U.S. Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Primary Hyperoxaluria Drug Market Share by Type in 2019
Figure 40. North America Primary Hyperoxaluria Drug Market Share by Application in 2019
Figure 41. Europe Primary Hyperoxaluria Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Primary Hyperoxaluria Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Primary Hyperoxaluria Drug Sales Market Share by Country in 2019
Figure 44. Europe Primary Hyperoxaluria Drug Revenue Market Share by Country in 2019
Figure 45. Germany Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Primary Hyperoxaluria Drug Market Share by Type in 2019
Figure 56. Europe Primary Hyperoxaluria Drug Market Share by Application in 2019
Figure 57. Asia Pacific Primary Hyperoxaluria Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Primary Hyperoxaluria Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Primary Hyperoxaluria Drug Sales Market Share by Region in 2019
Figure 60. Asia Pacific Primary Hyperoxaluria Drug Revenue Market Share by Region in 2019
Figure 61. China Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Primary Hyperoxaluria Drug Market Share by Type in 2019
Figure 84. Asia Pacific Primary Hyperoxaluria Drug Market Share by Application in 2019
Figure 85. Latin America Primary Hyperoxaluria Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Primary Hyperoxaluria Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Primary Hyperoxaluria Drug Sales Market Share by Country in 2019
Figure 88. Latin America Primary Hyperoxaluria Drug Revenue Market Share by Country in 2019
Figure 89. Mexico Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Primary Hyperoxaluria Drug Market Share by Type in 2019
Figure 96. Latin America Primary Hyperoxaluria Drug Market Share by Application in 2019
Figure 97. Middle East and Africa Primary Hyperoxaluria Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Primary Hyperoxaluria Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Primary Hyperoxaluria Drug Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Primary Hyperoxaluria Drug Revenue Market Share by Country in 2019
Figure 101. Turkey Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Primary Hyperoxaluria Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Primary Hyperoxaluria Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Primary Hyperoxaluria Drug Market Share by Type in 2019
Figure 108. Middle East and Africa Primary Hyperoxaluria Drug Market Share by Application in 2019
Figure 109. North America Primary Hyperoxaluria Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Primary Hyperoxaluria Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Primary Hyperoxaluria Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Primary Hyperoxaluria Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Primary Hyperoxaluria Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Primary Hyperoxaluria Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Primary Hyperoxaluria Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Primary Hyperoxaluria Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Primary Hyperoxaluria Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Primary Hyperoxaluria Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs